M Steben, MT Thompson, C Rodier, N Mallette… - Journal of Obstetrics and …, 2018 - Elsevier
Publicly funded administration of the quadrivalent HPV (qHPV) vaccine in school-aged girls was implemented for all Canadian provinces and territories between 2007 and 2009 …
T Palmer, L Wallace, KG Pollock, K Cuschieri… - bmj, 2019 - bmj.com
Objective To quantify the effect on cervical disease at age 20 years of immunisation with bivalent human papillomavirus (HPV) vaccine at age 12-13 years. Design Retrospective …
OBJECTIVES: We describe the final 10-year data for the long-term follow-up study of the 4- valent human papillomavirus (4vHPV) vaccine in preadolescents and adolescents …
E Navarro-Illana, M López-Lacort, P Navarro-Illana… - Vaccine, 2017 - Elsevier
Objectives To assess the effectiveness of the HPV vaccines in preventing genital warts in young women. Design Population-based study using health databases. Setting Valencian …
Abstract Background The National Advisory Committee on Immunization in Canada recommends human papillomavirus (HPV) vaccination for females and males (ages 9–26) …
BACKGROUND: Although cancer incidence over time is well documented in Canada, trends by birth cohort and age group are less well known. We analyzed age-and sex-standardized …
The need for a systematic approach to research on vaccine effectiveness (VE) is increasing with growing numbers of vaccines and complexity of immunization programs. The diverse …
M Oz, N Cetinkaya, A Apaydin, E Korkmaz… - Journal of Cancer …, 2018 - Springer
Awareness of HPV by the target population is an important determinant of vaccine acceptance. The aim of this study is to evaluate the awareness of HPV infection and …
J Kim, C Bell, M Sun, G Kliewer, L Xu, M McInerney… - Cmaj, 2016 - Can Med Assoc
Background: A school-based program with quadrivalent human papillomavirus (HPV) vaccination was implemented in Alberta in 2008. We assessed the impact of this program on …